These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30550356)

  • 1. Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality.
    Tamburini E; Dallatomasina A; Quartararo J; Cortelazzi B; Mangieri D; Lazzaretti M; Perris R
    FASEB J; 2019 Mar; 33(3):3112-3128. PubMed ID: 30550356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chondroitin sulfate proteoglycan 4 (NG2/CSPG4) on soft-tissue sarcoma growth depend on tumor developmental stage.
    Hsu SC; Nadesan P; Puviindran V; Stallcup WB; Kirsch DG; Alman BA
    J Biol Chem; 2018 Feb; 293(7):2466-2475. PubMed ID: 29196603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondroitin sulfate proteoglycan 4 enhanced melanoma motility and growth requires a cysteine in the core protein transmembrane domain.
    Yang J; Price MA; Wanshura LEC; He J; Yi M; Welch DR; Li G; Conner S; Sachs J; Turley EA; McCarthy JB
    Melanoma Res; 2019 Aug; 29(4):365-375. PubMed ID: 31140988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells.
    Cooney CA; Jousheghany F; Yao-Borengasser A; Phanavanh B; Gomes T; Kieber-Emmons AM; Siegel ER; Suva LJ; Ferrone S; Kieber-Emmons T; Monzavi-Karbassi B
    Breast Cancer Res; 2011 Jun; 13(3):R58. PubMed ID: 21658254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas.
    Schiffer D; Mellai M; Boldorini R; Bisogno I; Grifoni S; Corona C; Bertero L; Cassoni P; Casalone C; Annovazzi L
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate CSPG4 mutations and induced pluripotent stem cell modeling implicate oligodendrocyte progenitor cell dysfunction in familial schizophrenia.
    de Vrij FM; Bouwkamp CG; Gunhanlar N; Shpak G; Lendemeijer B; Baghdadi M; Gopalakrishna S; Ghazvini M; Li TM; Quadri M; Olgiati S; Breedveld GJ; Coesmans M; Mientjes E; de Wit T; Verheijen FW; Beverloo HB; Cohen D; Kok RM; Bakker PR; Nijburg A; Spijker AT; Haffmans PMJ; Hoencamp E; Bergink V; ; Vorstman JA; Wu T; Olde Loohuis LM; Amin N; Langen CD; Hofman A; Hoogendijk WJ; van Duijn CM; Ikram MA; Vernooij MW; Tiemeier H; Uitterlinden AG; Elgersma Y; Distel B; Gribnau J; White T; Bonifati V; Kushner SA
    Mol Psychiatry; 2019 May; 24(5):757-771. PubMed ID: 29302076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion.
    Cattaruzza S; Nicolosi PA; Braghetta P; Pazzaglia L; Benassi MS; Picci P; Lacrima K; Zanocco D; Rizzo E; Stallcup WB; Colombatti A; Perris R
    J Mol Cell Biol; 2013 Jun; 5(3):176-93. PubMed ID: 23559515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NG2/CSPG4 and progranulin in the posttraumatic glial scar.
    Schäfer MKE; Tegeder I
    Matrix Biol; 2018 Aug; 68-69():571-588. PubMed ID: 29054751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion.
    Tang F; Lord MS; Stallcup WB; Whitelock JM
    J Biochem; 2018 May; 163(5):399-412. PubMed ID: 29462330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B.
    Yuan P; Zhang H; Cai C; Zhu S; Zhou Y; Yang X; He R; Li C; Guo S; Li S; Huang T; Perez-Cordon G; Feng H; Wei W
    Cell Res; 2015 Feb; 25(2):157-68. PubMed ID: 25547119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The primary structure of NG2, a novel membrane-spanning proteoglycan.
    Nishiyama A; Dahlin KJ; Prince JT; Johnstone SR; Stallcup WB
    J Cell Biol; 1991 Jul; 114(2):359-71. PubMed ID: 1906475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel repeat in the melanoma-associated chondroitin sulfate proteoglycan defines a new protein family.
    Staub E; Hinzmann B; Rosenthal A
    FEBS Lett; 2002 Sep; 527(1-3):114-8. PubMed ID: 12220645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma.
    Price MA; Colvin Wanshura LE; Yang J; Carlson J; Xiang B; Li G; Ferrone S; Dudek AZ; Turley EA; McCarthy JB
    Pigment Cell Melanoma Res; 2011 Dec; 24(6):1148-57. PubMed ID: 22004131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chondroitin sulfate and cytoplasmic domain-dependent membrane targeting of the NG2 proteoglycan promotes retraction fiber formation and cell polarization.
    Stallcup WB; Dahlin-Huppe K
    J Cell Sci; 2001 Jun; 114(Pt 12):2315-25. PubMed ID: 11493670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface.
    Nishiyama A; Stallcup WB
    Mol Biol Cell; 1993 Nov; 4(11):1097-108. PubMed ID: 8305732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor Binding Domains of TcdB from
    Henkel D; Tatge H; Schöttelndreier D; Tao L; Dong M; Gerhard R
    Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33255261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors.
    Farnedi A; Rossi S; Bertani N; Gulli M; Silini EM; Mucignat MT; Poli T; Sesenna E; Lanfranco D; Montebugnoli L; Leonardi E; Marchetti C; Cocchi R; Ambrosini-Spaltro A; Foschini MP; Perris R
    BMC Cancer; 2015 May; 15():352. PubMed ID: 25935541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets.
    Girolamo F; Dallatomasina A; Rizzi M; Errede M; Wälchli T; Mucignat MT; Frei K; Roncali L; Perris R; Virgintino D
    PLoS One; 2013; 8(12):e84883. PubMed ID: 24386429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional roles of CSPG4/NG2 in chondrosarcoma.
    Jamil NS; Azfer A; Worrell H; Salter DM
    Int J Exp Pathol; 2016 Apr; 97(2):178-86. PubMed ID: 27292772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human melanoma/NG2 chondroitin sulfate proteoglycan is expressed in the sarcolemma of postnatal human skeletal myofibers. Abnormal expression in merosin-negative and Duchenne muscular dystrophies.
    Petrini S; Tessa A; Carrozzo R; Verardo M; Pierini R; Rizza T; Bertini E
    Mol Cell Neurosci; 2003 Jun; 23(2):219-31. PubMed ID: 12812755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.